Predictors for the Transition from Ductal Carcinoma In Situ to Invasive Breast Cancer in Korean Patients
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To identify predictive factors of upstaging from diagnosed ductal carcinoma in situ (DCIS) to invasive cancer after surgical excision. Methods: One hundred seventy-four patients diagnosed with DCIS based on biopsies between January 2009 and December 2014 were evaluated. Patients’ clinicopathological variables were assessed to identify predictive factors of invasive carcinoma from final pathology. Results: One hundred seventy-four cases of DCIS were included. Of these, 42 were upstaged to invasive carcinoma on the final excision. Preoperative features such as age 40 years or younger at diagnosis, presence of a palpable mass, ultrasonography (USG)-guided core needle biopsy, tumor size ≥20 mm on USG, high grade DCIS, cribriform DCIS, comedo necrosis, presence of intraluminal calcification, estrogen receptor negativity, progesterone receptor negativity and triple-negative subtype were significantly associated with the risk of invasive carcinoma. Multivariate analysis showed that a tumor size ≥20 mm on USG and triple negative subtype were independently associated with upstaging. Conclusion: Tumor size ≥20 mm on USG and triple-negative subtype were independently associated with the upstaging of DCIS to invasive cancer.
Abstract
Purpose: To identify predictive factors of upstaging from diagnosed ductal carcinoma in situ (DCIS) to invasive cancer after surgical excision. Methods: One hundred seventy-four patients diagnosed with DCIS based on biopsies between January 2009 and December 2014 were evaluated. Patients’ clinicopathological variables were assessed to identify predictive factors of invasive carcinoma from final pathology. Results: One hundred seventy-four cases of DCIS were included. Of these, 42 were upstaged to invasive carcinoma on the final excision. Preoperative features such as age 40 years or younger at diagnosis, presence of a palpable mass, ultrasonography (USG)-guided core needle biopsy, tumor size ≥20 mm on USG, high grade DCIS, cribriform DCIS, comedo necrosis, presence of intraluminal calcification, estrogen receptor negativity, progesterone receptor negativity and triple-negative subtype were significantly associated with the risk of invasive carcinoma. Multivariate analysis showed that a tumor size ≥20 mm on USG and triple negative subtype were independently associated with upstaging. Conclusion: Tumor size ≥20 mm on USG and triple-negative subtype were independently associated with the upstaging of DCIS to invasive cancer.
참고문헌 (29)
- Darling ML, "Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision", AJR Am J Roentgenol, 175, pp.1341~1346 (2000)
- Wahedna Y, "Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus", Eur J Cancer, 37, pp.459~462 (2001)
- Jackman RJ, "Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates", Radiology, 218, pp.497~502 (2001)
- King TA, "A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ", Am Surg, 67, pp.907~912 (2001)
- Cox D, "The significance of mammotome core biopsy specimens without radiographically identifiable microcalcification and their influence on surgical management: a retrospective review with histological correlation", Breast, 15, pp.210~218 (2006)
- Hoorntje LE, "The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy", Ann Surg Oncol, 10, pp.748~753 (2003)
- Yen TW, "Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ", J Am Coll Surg, 200, pp.516~526 (2005)
- Wilkie C, "An update of sentinel lymph node mapping in patients with ductal carcinoma in situ", Am J Surg, 190, pp.563~566 (2005)
- Han JS, "Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases", Breast J, 17, pp.223~229 (2011)
- Houssami N, "Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy", Ann Surg Oncol, 18, pp.1364~1371 (2011)
- Miyake T, "Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ", Am J Surg, 202, pp.59~65 (2011)
- Tan JC, "Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy", Ann Surg Oncol, 14, pp.638~645 (2007)
- Feldman SM, "Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy", J Am Coll Surg, 188, pp.248~254 (1999)
- Dillon MF, "Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only", J Surg Oncol, 93, pp.559~563 (2006)
- Lyman GH, "American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer", J Clin Oncol, 23, pp.7703~7720 (2005)
- van Deurzen CH, "Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review", Eur J Cancer, 43, pp.993~1001 (2007)
- Schouten van der Velden AP, "The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma", Am J Surg, 192, pp.172~178 (2006)
- Renshaw AA, "Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ", Arch Pathol Lab Med, 126, pp.39~41 (2002)
- Sakorafas GH, "Recent advances and current controversies in the management of DCIS of the breast", Cancer Treat Rev, 34, pp.483~497 (2008)
- Smith DN, "Large-core needle biopsy of nonpalpable breast cancers: the impact on subsequent surgical excisions", Arch Surg, 132, pp.256~259 (1997)
- Lee SK, "Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast", Br J Surg, 100, pp.1756~1763 (2013)
- Bagnall MJ, "Predicting invasion in mammographically detected microcalcification", Clin Radiol, 56, pp.828~832 (2001)
- Roses RE, "HER-2", neu overexpression as a predictor for the transition from in situ to invasive breast cancer, 2009, pp.18, 1386~1389
- Crystal P, "Using sonography to screen women with mammographically dense breasts", AJR Am J Roentgenol, 181, pp.177~182 (2003)
- Trentin C, "Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases", Breast, 21, pp.635~640 (2012)
- Burstein HJ, "Ductal car cinoma in situ of the breast", N Engl J Med, 350, pp.1430~1441 (2004)
- Tse GM, "Diagnosing breast lesions by fine needle aspiration cytology or core biopsy: which is better?", Breast Cancer Res Treat, 123, pp.1~8 (2010)
- Green S, "Excisional biopsy of borderline lesions after large bore vacuum-assisted core needle biopsy: is it necessary?", Am Surg, 77, pp.1358~1360 (2011)
- Kim J, "Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision", Breast, 21, pp.641~645 (2012)